Spice drugs as a new trend: mode of action, identification and legislation.
about
Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activityCannabinergic aminoalkylindoles, including AM678=JWH018 found in 'Spice', examined using drug (Δ(9)-tetrahydrocannabinol) discrimination for ratsHere today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazinesBeyond THC: The New Generation of Cannabinoid Designer DrugsGone to Pot - A Review of the Association between Cannabis and PsychosisSpice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoidsInterpretation of urine drug testing in pain patientsImpact of the emergence of designer drugs upon sports doping testingRapid identification of synthetic cannabinoids in herbal samples via direct analysis in real time mass spectrometryDistinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?Designer drugs 2015: assessment and management.Consumption of new psychoactive substances in a Spanish sample of research chemical users.Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans."Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans.Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDP-glucuronosyltransferasesHigh times, low sats: diffuse pulmonary infiltrates associated with chronic synthetic cannabinoid use.Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace.Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones.The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products."Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays.Development of a high-performance liquid chromatography-tandem mass spectrometry method for the identification and quantification of CP-47,497, CP-47,497-C8 and JWH-250 in mouse brain.Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.Direct screening of herbal blends for new synthetic cannabinoids by MALDI-TOF MS.Δ9-THC exposure attenuates aversive effects and reveals appetitive effects of K2/'Spice' constituent JWH-018 in mice.Synthetic cannabinoid use among patients in residential substance use disorder treatment: prevalence, motives, and correlates.Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in miceConvulsions associated with the use of a synthetic cannabinoid product.First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201.Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugsThe synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse.Marijuana: respiratory tract effects.Smart drugs: green shuttle or real drug?Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids.New drugs of abuse.AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in MiceDisrupted gamma-band neural oscillations during coherent motion perception in heavy cannabis users.CP47,497-C8 and JWH073, commonly found in 'Spice' herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonistsK2 toxicity: fatal case of psychiatric complications following AM2201 exposure.Using cheminformatics to predict cross reactivity of "designer drugs" to their currently available immunoassays.
P2860
Q21135310-12AAF688-387E-43C8-BFA4-B0C62E769287Q24630223-B66E8906-7FEB-4F44-BFFA-86A138E0992AQ24631675-61ECC7B2-04C3-42EC-919B-957E98E76AC0Q24635230-6EFAE034-B50C-4ED1-BBAD-D5BAE535F516Q26865311-38DB891F-5C78-4444-8875-85E22C0B84B4Q27010555-29182E09-9357-4FF3-B051-384195C8222BQ27011889-48DB9A70-A5AC-45E8-83A7-6BA1EAAE798BQ28255977-ADC96C49-400F-4E57-A96A-E804D9441958Q28263384-C5666E14-79ED-4522-B8AB-B1D53C0FA23AQ28540537-1B1D79D4-7EF0-4BF8-B827-A2802A19E8BDQ30300017-18052A8D-9F43-49D6-B601-3705E57AB0B8Q30352297-C8D34054-571C-4FA4-BEFC-46D49BD0DD34Q30377901-00B46698-6D3D-4183-907E-8981EF156E12Q30455650-D647B2CB-C213-4DFC-B175-0BDDC535C40FQ33160231-C1C49F7F-64E5-4CB9-9583-BBE86EE19701Q33162567-42995442-DF8B-4BD9-B4BC-D1F819A3128CQ33725088-DCD81903-DF67-432E-B04F-5EDE37795A85Q33906178-FBB6B75D-998A-4709-BC91-BC02A6B55059Q33908169-689BFC87-F165-4C25-AADE-4546EC45FC8FQ34055910-180CCBFA-A804-42ED-B890-A52EA2DE4028Q34106241-FBC3D65B-6D8E-4113-9204-223FB42FE695Q34115633-432863C7-479E-4FEE-9D76-D351E3DA7EDFQ34142699-8417A351-D996-4134-8972-343FFBBC1ABAQ34148141-CB72AB79-9D0E-456C-A8A7-B593246B5F52Q34167511-946605D7-CA89-41BD-AFBC-E727C228FE4CQ34173626-401AAF6D-7A4A-43FC-80FF-4FFFC19B6542Q34236794-1D905945-5017-42B2-8530-C24D4FE4EA88Q34240070-9830E87A-4C19-4477-B223-BB5797C87B30Q34296844-B9BD9AE9-5AC6-4DCB-8541-A3AFFA109061Q34314602-18E79DFC-5501-4A86-AEDF-E8D17C49C156Q34336690-044BC1BB-74A0-4230-837B-E19267175473Q34347280-534A05E7-092B-464F-BD1A-9CE6C6FCCCE4Q34356671-0B0FD3E4-1767-4031-9B0E-B5B792EBCB46Q34373631-C5E8BD39-E130-4AE2-B84F-636200893624Q34451886-B7079E8C-8A35-49F4-B3D7-6635DA42BCD1Q34482035-6D39303E-A671-430E-BC40-AD080E983643Q34499364-3FC97DBA-C66F-46BC-AEA4-AA97313792EAQ34981205-1FD6F87C-68DA-4B16-8E78-1DDF81964272Q35057032-5EBB5CD3-2DEA-46C9-B39F-41D8ECBC8F41Q35172366-51D0E4F7-430D-46F6-9FA1-89F5EEACB8EF
P2860
Spice drugs as a new trend: mode of action, identification and legislation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Spice drugs as a new trend: mode of action, identification and legislation.
@ast
Spice drugs as a new trend: mode of action, identification and legislation.
@en
Spice drugs as a new trend: mode of action, identification and legislation.
@nl
type
label
Spice drugs as a new trend: mode of action, identification and legislation.
@ast
Spice drugs as a new trend: mode of action, identification and legislation.
@en
Spice drugs as a new trend: mode of action, identification and legislation.
@nl
prefLabel
Spice drugs as a new trend: mode of action, identification and legislation.
@ast
Spice drugs as a new trend: mode of action, identification and legislation.
@en
Spice drugs as a new trend: mode of action, identification and legislation.
@nl
P2093
P1433
P1476
Spice drugs as a new trend: mode of action, identification and legislation.
@en
P2093
Ch Spiliopoulou
I Vardakou
P304
P356
10.1016/J.TOXLET.2010.06.002
P577
2010-06-08T00:00:00Z